R1 RCM — Accretive Health — Investor Presentation (September 2016)
29 slides from R1 RCM's investor presentation, Sep 28, 2016
Slide 1: Investor Presentation September 2016
Investor Presentation September 2016 Exhibit 99.1
Slide 2: Safe Harbor Statement
©2013 Accretive Health Inc. Safe Harbor Statement 2 This presentation contains forward-looking statements, including statements regarding future growth, plans and performance. All forward-looking statements contained in this presentation involve risks and uncertainties. The Company’s actual results
Slide 3: Use of Non-GAAP Measures
©2013 Accretive Health Inc. Use of Non-GAAP Measures 3 · In order to provide a more comprehensive understanding of the information used by Accretive Health’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain
Slide 4: Contents
©2013 Accretive Health Inc. Contents 4 · Who We Are · Industry Dynamics · Differentiated Value Proposition · Strategy and Financials · Appendix
Slide 5: Who We Are: A Leader in Revenue Cycle Management
©2013 Accretive Health Inc. A Leader in Revenue Cycle Management… The largest pure-play provider of outsourced revenue cycle management (RCM) services to healthcare providers …with End-to-End Capability… We optimize the full spectrum of revenue cycle operations – functions ranging from patient pre-r
Slide 6: Company Profile
©2013 Accretive Health Inc. Company Profile 6 Equity snapshot Ticker: ACHI (OTC1) IPO: May 2010 Market Cap2: ~$380M 2015 top-line: $230M Operational highlights Customers: 72 hospitals Global Shared Services Centers 3,500 employees 1 We expect to list on one of the major exchanges in early 2017 2 Mar
Slide 7: Why Invest in Accretive Health?
©2013 Accretive Health Inc. Why Invest in Accretive Health? 7 Leader in a nascent market: <10% of Hospital RCM spend is outsourced to service providers Significant Competitive Advantages: Only service provider with robust technology and scalable infrastructure encapsulated in a proprietary opera
Slide 8: Contents
©2013 Accretive Health Inc. Contents 8 · Who We Are · Industry Dynamics · Differentiated Value Proposition · Strategy and Financials · Appendix
Slide 9: Several Forces are Reshaping Revenue Cycle Management
©2013 Accretive Health Inc. Several Forces are Reshaping Revenue Cycle Management 9 • Declining reimbursement • Increasing patient responsibility, with poor collection rates • Emerging payment models • ICD-10 • Consumerism • Regional consolidation of health systems • Integration across continuum of
Slide 10: Outsourced RCM Services: Fastest Growing Segment of the RCM Market
©2013 Accretive Health Inc. Outsourced RCM Services: Fastest Growing Segment of the RCM Market 10 Source: CMS NHE Projections, KPMG, Accretive Health Estimates 52.2 8.8 7.7 16.5 2015: $51.6B 2020: $68.7B In-House RCM Spend External RCM Spend Outsourced RCM Services External RCM Apps / Software 43.3
Slide 11: Contents
©2013 Accretive Health Inc. Contents 11 · Who We Are · Industry Dynamics · Differentiated Value Proposition · Strategy and Financials · Appendix
Slide 12: We Have Three Core Value Propositions
©2013 Accretive Health Inc. We Have Three Core Value Propositions… 12 Lower Cost of Revenue Cycle Operations Improve Revenue Collections Manage Emerging Payment Models 1 3 2
Slide 13: Delivered Through Three Deployment Models
©2013 Accretive Health Inc. …Delivered Through Three Deployment Models 13 • Full control over customer revenue cycle operations • Customer employees transition to Accretive Health • Complementary talent deployed on-site to work with customer’s revenue cycle team • Certain functions performed from sh
Slide 14: Differentiated Approach to Driving Value: End-to-End Insight
©2013 Accretive Health Inc. Differentiated Approach to Driving Value: End-to-End Insight, Powered by Proprietary Capabilities 14 HITRUST Compliant
Slide 15: Our Operating System is Built on a Decade-plus of Experience
©2013 Accretive Health Inc. Our Operating System is Built on a Decade-plus of Experience 15 Operating System Technology Shared Services Analytics · Over 150 detailed methods for operational excellence, supported by >100 proprietary operating measures · Full alignment to the five financial outcomes w
Slide 16: Processes and Workflows are Supported by Proprietary Technology
©2013 Accretive Health Inc. Processes and Workflows are Supported by Proprietary Technology 16 Operating System Technology Shared Services Analytics · Technology automates & institutionalizes our operations – 80% of operating methods are powered by AH technology · Enables scaled operations and distr
Slide 17: Shared Services Centers Provide a Lever for Cost Reduction
©2013 Accretive Health Inc. Shared Services Centers Provide a Lever for Cost Reduction 17 Operating System Technology Shared Services Analytics · Domestic and offshore shared services infrastructure · Networked to allow seamless transition of work between different locations · Centralization of func
Slide 18: Analytics Capabilities Provide Powerful Business Insights
©2013 Accretive Health Inc. Analytics Capabilities Provide Powerful Business Insights 18 Operating System Technology Shared Services Analytics · Repository of >300 intelligence reports tied to value creation · Integration with applications activity data provides unique operational analytics capabili
Slide 19: Contents
©2013 Accretive Health Inc. Contents 19 · Who We Are · Industry Dynamics · Differentiated Value Proposition · Strategy and Financials · Appendix
Slide 20: Near-Term Strategy to Re-launch the Company
©2013 Accretive Health Inc. Near-Term Strategy to Re-launch the Company 20 1) Generate Compelling Proof Points from Ascension Deployment • Demonstrate value proposition by achieving financial performance targets • Establish scaling as a competitive advantage via deployment approach 2) Increase Exter
Slide 21: Ascension Contract Provides Stability, Growth and Visibility
©2013 Accretive Health Inc. Ascension Contract Provides Stability, Growth and Visibility 21 10-year agreement $8+ billion in new net patient revenue (NPR) Three-year onboarding plan beginning 2H’16 Agreement signed Feb. 2016 1st Tranche onboarding (~$3B NPR) 2H’16 to 1H’17 Launched Deployment
Slide 22: Financials: Intro to Non-GAAP Measures
©2013 Accretive Health Inc. Financials: Intro to Non-GAAP Measures 22 Gross Cash Generated from Customer Contracting Activities GAAP revenue plus change in deferred customer billings Net Cash Generated from Customer Contracting Activities GAAP net income less interest, taxes, depreciation and amorti
Slide 23: Financial Model Illustrative
©2013 Accretive Health Inc. Financial Model 23 Illustrative1 Revenue and EBITDA margins by Contract Type Full-Outsource Model Co-Managed Model Modular Services Gross Cash Generated from Customer Contracting Activities Net Cash Generated from Customer Contracting Activities Yr 1 Yr 5 20-25 40-50 5-8
Slide 24: 2020 Outlook: Healthy Growth as new Ascension Business is Onboarded
©2013 Accretive Health Inc. ~90% of low-end currently contracted* 2020 Outlook: Healthy Growth as new Ascension Business is Onboarded 24 2016 Expectations $220 $200 2020 Expectations $900 $700 G ro ss C as h G en er at ed fr om C us to m er Co nt ra ct in g A ct iv it ie s ($ M M ) Mid- to high-teen
Slide 25: Contents
©2013 Accretive Health Inc. Contents 25 · Who We Are · Industry Dynamics · Differentiated Value Proposition · Strategy and Financials · Appendix
Slide 26: Condensed Non-GAAP P&L
©2013 Accretive Health Inc. Condensed Non-GAAP P&L 26 ($ in millions) 2013 2014 2015 2016E Gross Cash Generated from Cust. Contracting Activities $251.6 $233.6 $230.2 $200 - $220 Operating expenses: Cost of Sales $171.3 $170.9 $154.2 N/P SG&A $64.8 $54.9 $49.6 N/P Net Cash Generated from Cust. Contr
Slide 27: GAAP Consolidated Statement of Operations
©2013 Accretive Health Inc. GAAP Consolidated Statement of Operations 27 ($ in thousands, except per share data) 2013 2014 2015 Q1 2016 Q2 2016 Net services revenue $504,768 $210,140 $117,239 $352,193 $8,672 Operating expenses : Cost of services 186,752 182,144 168,977 45,130 45,112 Sel l ing, gener
Slide 28: Reconciliation of GAAP to Non-GAAP Financials
©2013 Accretive Health Inc. Reconciliation of GAAP to Non-GAAP Financials 28 ($ in thousands , except per share data) 2013 2014 2015 Q1 2016 Q2 2016 Tota l net services revenue $504,768 $210,140 $117,239 $352,193 $8,672 Change in deferred customer bi l l ings (253,127) 23,427 112,938 (311,339) 29,60
Slide 29: Summary of Convertible Preferred Shares and Warrants Issued to Ascension-TowerBrook
©2013 Accretive Health Inc. Summary of Convertible Preferred Shares and Warrants Issued to Ascension-TowerBrook 29 Convertible Preferred Stock $200 million of convertible preferred stock is convertible into Accretive common stock at $2.50 per share 8.0% annual dividend, payable in-kind on a quar
Accretive Health — Investor Presentation (September 2016) on 6ix